Neurocrine Biosciences (NBIX) Financials: Revenue & Earnings

NBIX price $145.28 -0.72 -0.50%

Ticker
NBIX
Price
$145.28
Change
-0.72 -0.50%
Market cap ?
$14.77B
P/E ?
20.71
Forward P/E ?
20.32
Dividend yield ?
0.00%
Beta ?
0.40
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
67
Value
56
Quality
66
Growth
79

Stocklytics score rationale: value 56, quality 66, growth 79.

Financials

2016201720182019202020212022202320242025
15000000161626000451200000788100000104590000011335000001488700000188710000023553000002860500000

Neurocrine Biosciences, Inc. is a pharmaceutical firm dedicated to the creation, advancement, and commercialization of medicines addressing a spectrum of neurological, endocrine, and psychiatric conditions. Its current therapeutic pipeline and marketed products target disorders such as tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, alongside numerous experimental compounds in various…

Fair value

NBIX fair value $359.55. Price $145.28. Price is 60% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 95% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 870.40M. Growth 18.88%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 101.65M. Net debt -297.70M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare NBIX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-02—1.93—1.05B
2026-07-302.851.85959.00M890.33M
2026-05-051.911.22814.50M768.25M
2026-02-111.881.80805.50M790.50M
2025-10-282.041.58794.90M806.80M
2025-07-301.060.98687.50M746.41M
2025-05-050.080.54572.60M559.63M
2025-02-061.001.62627.70M629.44M
2024-10-301.241.51622.10M600.64M
2024-08-010.631.05590.20M545.94M
2024-05-010.421.01515.30M512.40M
2024-02-071.441.15515.20M519.12M
2023-10-310.820.97498.80M468.15M
2023-08-010.950.78452.70M447.31M
2023-05-03-0.790.26420.40M409.26M
2023-02-060.881.16412.00M408.87M
2022-11-010.690.79387.90M377.00M
2022-08-04-0.180.56378.20M342.33M
2022-05-040.140.35310.60M304.07M
2022-02-11-0.080.61312.00M317.49M
2021-11-010.230.51296.00M296.58M
2021-08-030.430.48288.90M288.90M
2021-05-050.330.51236.60M253.22M
2021-02-043.580.59247.90M263.57M
2020-11-09-0.620.11258.50M1.12B
2020-08-030.810.73302.40M276.27M
2020-05-060.820.56237.10M328.29M
2020-02-040.350.75244.10M522.88M
2019-11-040.560.64222.09M253.82M
2019-07-290.370.24183.58M37.40M
2019-04-29-1.12-1.05138.40M113.69M
2019-02-050.190.18131.49M124.57M
2018-11-050.520.46151.76M134.25M
2018-07-31-0.07-0.1896.91M235.34M
2018-04-30-0.47-0.3271.09M45.37M
2018-02-130.070.1894.52M243.04M
2017-11-01-0.13-0.4960.77M224.40M
2017-08-03-0.68-0.676.33M6.15M
2017-05-09-0.90-0.67——
2017-02-14-0.51-0.55——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-28ROBERTS EIRYOther0——
2026-09-28ROBERTS EIRYOther17.15K$102.901.76M
2026-09-28ROBERTS EIRYOther48.20K$117.635.67M
2026-09-28ROBERTS EIRYOther60.01K$79.024.74M
2026-09-28ROBERTS EIRYOther965$103.5299.90K
2026-09-28ROBERTS EIRYOther51.57K$103.525.34M
2026-09-28ROBERTS EIRYOther747$133.8499.98K
2026-09-28ROBERTS EIRYOther21.78K$133.842.92M
2026-09-28ROBERTS EIRYOther27.77K$136.693.80M
2026-09-28ROBERTS EIRYOther853$117.1899.95K
2026-09-28ROBERTS EIRYOther42.41K$117.184.97M
2026-09-28ROBERTS EIRYOther10.09K$124.121.25M
2026-09-28ROBERTS EIRYOther2.95K——
2026-09-14Boyer David W.Sell826$157.45130.05K
2026-09-14ABERNETHY MATTSell2.31K$157.20363.28K
2026-09-11Onyia JudeBuy3.59K——
2026-09-11Onyia JudeSell1.94K$156.22302.44K
2026-09-11Lippoldt DarinBuy4.48K——
2026-09-11Lippoldt DarinSell2.42K$156.22377.90K
2026-09-11Keswani Sanjay ChandruBuy3.91K——
2026-09-11Keswani Sanjay ChandruSell2.11K$156.22329.94K
2026-09-11GORMAN KEVIN CHARLESBuy14.34K——
2026-09-11GORMAN KEVIN CHARLESSell7.84K$156.221.22M
2026-09-11Gano KyleBuy6.28K——
2026-09-11Gano KyleBuy1.84K——
2026-09-11Gano KyleSell994$156.22155.28K
2026-09-11Gano KyleSell3.39K$156.22528.96K
2026-09-11Delaet IngridBuy4.48K——
2026-09-11Delaet IngridSell2.42K$156.22377.90K
2026-09-11Cooke JulieBuy3.59K——
2026-09-11Cooke JulieSell1.94K$156.22302.44K
2026-09-11Boyer David W.Buy3.59K——
2026-09-11Boyer David W.Sell1.94K$156.22302.44K
2026-09-11BENEVICH ERICBuy6.28K——
2026-09-11BENEVICH ERICSell3.39K$156.22528.96K
2026-09-11ABERNETHY MATTBuy5.02K——
2026-09-11ABERNETHY MATTSell2.71K$156.22423.20K
2026-09-09BENEVICH ERICBuy3.19K$43.24138.11K
2026-09-09BENEVICH ERICSell2.15K$154.61333.03K
2026-09-09BENEVICH ERICSell3.19K$43.24138.11K
2026-09-02SHERWIN STEPHEN ASell1.00K——
2026-08-04Onyia JudeSell2.41K——
2026-07-29Norwalk Leslie VBuy842$139.43117.40K
2026-07-29Norwalk Leslie VSell842$139.43117.40K
2026-07-28Norwalk Leslie VSell1.25K$182.01227.51K
2026-07-10Delaet IngridBuy4.37K$106.02462.99K
2026-07-10Delaet IngridSell4.37K$181.02790.51K
2026-07-10Delaet IngridSell4.37K$106.02462.99K
2026-07-09Lippoldt DarinBuy10.00K$81.49814.90K
2026-07-09Lippoldt DarinSell10.00K$179.601.80M
2026-07-09Lippoldt DarinSell10.00K$81.49814.90K
2026-07-09Delaet IngridBuy8.43K$103.52872.98K
2026-07-09Delaet IngridSell8.43K$178.721.51M
2026-07-09Delaet IngridSell8.43K$103.52872.98K
2026-07-08Delaet IngridBuy2.74K$103.52283.33K
2026-07-08Delaet IngridSell2.74K$178.54488.67K
2026-07-08Delaet IngridSell2.74K$103.52283.33K
2026-07-07Delaet IngridBuy3.40K$103.52352.07K
2026-07-07Delaet IngridSell3.40K$103.52352.07K
2026-07-07Delaet IngridSell3.40K$178.57607.31K
2026-06-29Lippoldt DarinBuy8.11K$81.49660.88K
2026-06-29Lippoldt DarinBuy1.69K$81.49137.72K
2026-06-29Lippoldt DarinSell8.11K$170.031.38M
2026-06-29Lippoldt DarinSell1.69K$170.81288.68K
2026-06-29Lippoldt DarinSell8.11K$81.49660.88K
2026-06-29Lippoldt DarinSell1.69K$81.49137.72K
2026-06-26Lippoldt DarinBuy200$81.4916.30K
2026-06-26Lippoldt DarinSell200$169.5633.91K
2026-06-26Lippoldt DarinSell200$81.4916.30K
2026-06-05SHERWIN STEPHEN ABuy10.00K$79.79797.90K
2026-06-05SHERWIN STEPHEN ASell7.88K$163.811.29M
2026-06-05SHERWIN STEPHEN ABuy15.00K$53.64804.60K
2026-06-05SHERWIN STEPHEN ASell2.55K$164.44419.16K
2026-06-05SHERWIN STEPHEN ASell6.90K$165.791.14M
2026-06-05SHERWIN STEPHEN ASell5.83K$166.56970.86K
2026-06-05SHERWIN STEPHEN ASell1.84K$167.31308.36K
2026-06-05SHERWIN STEPHEN ASell15.00K$53.64804.60K
2026-06-05SHERWIN STEPHEN ASell10.00K$79.79797.90K
2026-06-05Onyia JudeSell2.44K——
2026-06-04Norwalk Leslie VSell1.25K$168.06210.07K
2026-06-02Cooke JulieBuy24.96K$81.492.03M
2026-06-02Cooke JulieSell14.21K$154.832.20M
2026-06-02Cooke JulieSell5.47K$155.46849.73K
2026-06-02Cooke JulieSell4.22K$156.77660.93K
2026-06-02Cooke JulieSell9.52K$157.621.50M
2026-06-02Cooke JulieSell3.52K$158.59558.24K
2026-06-02Cooke JulieSell24.96K$81.492.03M
2026-06-02Keswani Sanjay ChandruSell3.21K——
2026-06-02Keswani Sanjay ChandruBuy3.21K——
2026-06-02Keswani Sanjay ChandruSell1.73K$154.84268.34K
2026-06-01Onyia JudeBuy11.00K$84.74932.14K
2026-06-01Onyia JudeSell11.00K$160.251.76M
2026-06-01Onyia JudeSell11.00K$84.74932.14K
2026-05-29Delaet IngridBuy2.26K$79.02178.66K
2026-05-29Delaet IngridSell2.26K$156.71354.32K
2026-05-29Delaet IngridSell2.26K$79.02178.66K
2026-05-27Onyia JudeBuy11.00K$84.74932.14K
2026-05-27Onyia JudeSell11.00K$155.531.71M
2026-05-27Onyia JudeSell11.00K$84.74932.14K
2026-05-27GORMAN KEVIN CHARLESBuy5.25K$155.83817.80K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 798, holders +78 vs prior quarter. Ownership 101.50%.

HolderSharesChangeChange %Value
BLACKROCK, INC.13.71M326.00K+2.44%2.31B
JPMORGAN CHASE & CO6.40M956.61K+17.58%1.09B
DODGE & COX5.58M123.67K+2.26%941.22M
VANGUARD PORTFOLIO MANAGEMENT LLC4.97M247.74K+5.24%838.31M
VANGUARD CAPITAL MANAGEMENT LLC4.55M33.44K+0.74%766.05M
STATE STREET CORP4.39M31.07K+0.71%739.13M
AQR CAPITAL MANAGEMENT LLC3.82M-1.12M-22.70%643.47M
RENAISSANCE TECHNOLOGIES LLC2.34M-83.00K-3.43%393.68M
GEODE CAPITAL MANAGEMENT, LLC2.14M2.10K+0.10%359.61M
TWO SIGMA INVESTMENTS, LP2.08M-984.31K-32.16%349.92M
VESTAL POINT CAPITAL, LP1.88M630.00K+50.40%316.85M
BNP PARIBAS ASSET MANAGEMENT HOLDING S.A.1.49M446+0.03%251.86M
MORGAN STANLEY1.32M99.41K+8.15%222.23M
RTW INVESTMENTS, LP1.27M205.85K+19.38%213.69M
NORTHERN TRUST CORP1.26M16.89K+1.36%212.31M
INVESCO LTD.1.08M721.31K+202.61%181.57M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.974.28K974.28KNew164.20M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC974.28K71.49K+7.92%164.20M
NORGES BANK973.88K973.88KNew164.13M
FIRST TRUST ADVISORS LP923.12K-36.09K-3.76%155.58M
DIMENSIONAL FUND ADVISORS LP732.88K21.11K+2.97%123.53M
JACOBS LEVY EQUITY MANAGEMENT, INC726.11K205.84K+39.56%122.38M
BANK OF NEW YORK MELLON CORP699.12K-3.37K-0.48%117.83M
SWEDBANK AB651.08K71.65K+12.37%109.73M
VANGUARD FIDUCIARY TRUST CO647.76K13.42K+2.12%109.17M

Earnings and financials

Neurocrine Biosciences, Inc. (NBIX) trades at $145.28, with a market cap of $14.77B and a trailing P/E of 20.71. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
15000000161626000451200000788100000104590000011335000001488700000188710000023553000002860500000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Neurocrine Biosciences (NBIX) Financials: Revenue & Earnings

NBIX$145.28-0.72 -0.50%

$14.77B

Market Cap

20.71

P/E

20.32

Forward P/E

67

Score

Price History